Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Use of candidate gene markers to guide antipsychotic dosage adjustment.

Progress in neuro-psychopharmacology & biological psychiatry - 3 Oct 2014

Hettige Nuwan C, Zai Clement, Hazra Monica, Borlido Carol, Kennedy James L, Strauss John, Le Foll Bernard, Wong Albert, Remington Gary, De Luca Vincenzo

Abstract excerpt

OBJECTIVE: To improve antipsychotic treatment in schizophrenia patients, many studies have investigated genetic polymorphisms associated with antipsychotic metabolizing enzymes and receptors. While these studies have typically focused on drug response, few have investigated genetic influences on antipsychotic dosage. This study set out to analyze the association between 134 SNPs in 38 candidate genes and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Biomarkers, Pharmacological

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cross-Sectional Studies

Share to Genotyping Techniques

Share to Glial Cell Line-Derived Neurotrophic Factor Receptors

Share to Psychotic Disorders

Share to Schizophrenia

Share to Young Adult

Source

Identifiers

PMID: 25016278
DOI: 10.1016/j.pnpbp.2014.07.001

Genes

GFRA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Use of candidate gene markers to guide antipsychotic dosage adjustment.PMID 25016278Read ↗

Candidate gene analysis of pharmacodynamic targets for antipsychotic dosage.Semantic proximity Read ↗

Genome-wide association analysis to predict optimal antipsychotic dosage in schizophrenia: a pilot study.Semantic proximity Read ↗

Polygenic risk score prediction of antipsychotic dosage in schizophrenia.Semantic proximity Read ↗

Polygenic Liability for Antipsychotic Dosage and Polypharmacy - A Real-World Registry and Biobank StudySemantic proximity Read ↗

Toward understanding genetic risk for differential antipsychotic response in individuals with schizophreniaSemantic proximity Read ↗

Pharmacogenetics of AntipsychoticsSemantic proximity Read ↗

Genetic determinants of variable metabolism have little impact on the clinical use of leading antipsychotics in the CATIE study.Semantic proximity Read ↗

Pharmacogenetics of antipsychotics: Clinical utility and implementationSemantic proximity Read ↗

Pharmacogenetics of Antipsychotic Drug Treatment: Update and Clinical ImplicationsSemantic proximity Read ↗

An Effective Method to Facilitate Personalized and Precise Medicine for Schizophrenia Treatment Based on PharmacogenomicsSemantic proximity Read ↗

Differing response to antipsychotic therapy in schizophrenia: pharmacogenomic aspectsSemantic proximity Read ↗

Genomic stratification of clozapine prescription patterns using schizophrenia polygenic scoresSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.